Pasar al contenido principal

CARACTERIZACION DE LA PREPARACION DEL NICHO METASTASICO PULMONAR A TRAVES DE UNA DIETA ALTA EN GRASAS EN CANCER DE MAMA METASTASICO

PID2023-152426OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities

  • Liu, Yawen
  • Zong, Xiangyun
  • Altea-Manzano, Patricia
  • Fu, Jie
Amino acid metabolism plays a critical role in the progression and development of breast cancer. Cancer cells, including those in breast cancer, reprogram amino acid metabolism to meet the demands of rapid proliferation, survival, and immune evasion. This includes alterations in the uptake and utilization of amino acids, such as glutamine, serine, glycine, and arginine, which provide essential building blocks for biosynthesis, energy production, and redox homeostasis. Notably, the metabolic phenotypes of breast cancer cells vary across molecular subtypes and disease stages, emphasizing the need for patient stratification and personalized therapeutic strategies. Advances in multi-level diagnostics, including phenotyping and predictive tools, such as AI-based analysis and body fluid profiling, have highlighted the potential for tailoring treatments to individual metabolic profiles. Enzymes, such as glutaminase and serine hydroxymethyltransferase, often upregulated in breast cancer, represent promising therapeutic targets. Understanding the interplay between amino acid metabolism and breast cancer biology, alongside the integration of personalized medicine approaches, can uncover novel insights into tumor progression and guide the development of precision therapies. This review explores the metabolic pathways of amino acids in breast cancer, with a focus on their implications for personalized treatment strategies., We apologize to the colleagues whose relevant work could not be cited in this review due to space constraints. YL receives funding from the National Natural Science Foundation of China (82403542), Shanghai Pujiang Program (24PJD086) and Fundamental research projects of the hospital level of Shanghai Sixth People’s Hospital (ynqn202424). PA-M acknowledges funding from European Research Council (ERC-StG-101116912), MCIN/AEI/10.13039/501100011033 and European Union (PID2023-152426OA-I00) and Beug Foundation., Peer reviewed